位元堂二零二四年中期报告

ContentContent Corporate Information BOARD OF DIRECTORS Executive Directors Mr. Tang Ching Ho,GBS, JP,Chairman & Managing Director Ms. Tang Wai ManMs. Law Man Yee, Anita Independent Non-executive Directors Mr. Li Ka Fai, David,MHProfessor Sit Wing Hang,GBS, JPProfessor Chan Wing Kwong,MDMr. Siu Man Ho, Simon(Resigned on 1 November 2024) AUDIT COMMITTEE Mr. Li Ka Fai, David,MH,ChairmanProfessor Sit Wing Hang,GBS, JPProfessor Chan Wing Kwong,MD REMUNERATION COMMITTEE Professor Sit Wing Hang,GBS, JP,ChairmanProfessor Chan Wing Kwong,MDMr. Li Ka Fai, David,MHMr. Tang Ching Ho,GBS, JPMs. Tang Wai Man NOMINATION COMMITTEE Professor Chan Wing Kwong,MD,ChairmanProfessor Sit Wing Hang,GBS, JPMr. Li Ka Fai, David,MHMr. Tang Ching Ho,GBS, JPMs. Tang Wai Man EXECUTIVE COMMITTEE Mr. Tang Ching Ho,GBS, JP,ChairmanMs. Tang Wai ManMs. Law Man Yee, Anita AUTHORISED REPRESENTATIVES Under Listing RulesMr. Tang Ching Ho,GBS, JPMs. Ng Yee Man Fiona COMPANY SECRETARY Ms. Ng Yee Man Fiona AUDITOR Ernst & YoungCertified Public AccountantsRegistered Public Interest Entity Auditor LEGAL ADVISERS • Reed Smith Richards Butler LLPGallantSullivan & Cromwell (Hong Kong) LLP PRINCIPAL BANKERS United Overseas Bank Limited, Hong Kong BranchTaiwan Shin Kong Commercial Bank Co., Ltd.CTBC Bank Co., Ltd.The Hongkong and Shanghai Banking Corporation Limited REGISTERED OFFICE Clarendon House2 Church StreetHamilton HM 11Bermuda Clarendon House2 Church StreetHamilton HM 11Bermuda HEAD OFFICE AND PRINCIPAL PLACE OF BUSINESS INHONG KONG Suite 3101, 31/F., Skyline Tower39 Wang Kwong RoadKowloon BayKowloonHong Kong 39313101 Corporate Information(Continued) PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE INBERMUDA MUFG Fund Services (Bermuda) Limited4th floor North Cedar House41 Cedar AvenueHamilton HM 12Bermuda MUFG Fund Services (Bermuda) Limited4th floor North Cedar House41 Cedar AvenueHamilton HM 12Bermuda(to be ceased on 1 January 2025) Appleby Global Corporate Services (Bermuda) Limited Appleby Global Corporate Services (Bermuda)LimitedCanon’s Court22 Victoria StreetPO Box HM 1179Hamilton HM EXBermuda Canon’s Court22 Victoria StreetPO Box HM 1179Hamilton HM EXBermuda(to be appointed on 1 January 2025) BRANCH SHARE REGISTRAR AND TRANSFER OFFICE INHONG KONG Tricor Investor Services Limited(to be appointed on 2 December 2024)Tricor Secretaries Limited(to be ceased on 2 December 2024)17/F, Far East Finance Centre16 Harcourt RoadHong Kong 1617 BOARD LOT 5,000 5,000 shares pr@waiyuentong.com Email: pr@waiyuentong.com www.wyth.net www.wyth.net STOCK CODE 897 897 Interim Dividend Interim Dividend The board of directors (the “Board” or the “Directors”) of Wai YuenTong Medicine Holdings Limited (the “Company”, together with itssubsidiaries, collectively the “Group”) does not recommend the paymentof any interim dividend for the six months ended 30 September 2024 (sixmonths ended 30 September 2023: Nil). * Management Discussion andAnalysis FINANCIAL RESULTS Revenue For the six months ended 30 September 2024 (the “Period”), totalrevenue of the Group decreased by approximately HK$21.5 millionto approximately HK$346.8 million, which was mainly attributable toweakened sales performance of Chinese pharmaceutical and health foodproducts. 21,500,000346,800,000 Gross profit The Group’s gross profit decreased by approximately HK$4.2 million orapproximately 2.3% to approximately HK$182.0 million for the Period ascompared to approximately HK$186.2 million for the six months ended30 September 2023. The decrease was mainly due to decrease in saleof Chinese pharmaceutical and health food products. 186,200,0004,200,0002.3%182,000,000 Other income and gains, net Other income and gains of the Group decreased by approximatelyHK$23.4 million or approximately 33.6% from approximately HK$69.6million for the six months ended 30 September 2023 to approximatelyHK$46.2 million for the Period. The decrease was mostly because ofreduced gain on disposal of items of property, plant and equipment ascompared with the corresponding period in 2023. 69,600,00023,400,00033.6%46,200,000 Selling and distribution expenses Selling and distribution expenses increased by approximately HK$20.0million or approximately 17.9% from approximately HK$111.9 million forthe six months ended 30 September 2023 to approximately HK$131.9million for the Period. The increase was mainly owing to increasedmarketing cost for new products launched and expansion of e-commercebusiness. 111,900,00020,000,00017.9%131,900,000 Management Discussion and Analysis(Continued) Administrative expenses Administrative expenses increased by approximately HK$8.3 million orapproximately 15.1% from approximately HK$55.1 million for the sixmonths ended 30 September 2023 to approximately HK$63.4 millionfor the Period. The increase was mainly due to increase in legal andprofessional fee. 55,100,0008,300,00015.1%63,400,000 Other expenses, net Other expenses decreased